GI
LGND icon

GAMMA Investing’s Ligand Pharmaceuticals LGND Stock Holding History

GAMMA Investing’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$254K Buy
813
+132
+19% +$39K 0.01% 1151
2026
Q2 		$215K Buy
681
+37
+6% +$8.72K 0.01% 1223
2026
Q1 		$129K Buy
644
+17
+3% +$3.36K 0.01% 1464
2025
Q4 		$119K Buy
627
+52
+9% +$9.99K 0.01% 1454
2025
Q3 		$102K Buy
575
+63
+12% +$9.37K 0.01% 1502
2025
Q2 		$58.2K Sell
512
-81
-14% -$8.66K ﹤0.01% 1830
2025
Q1 		$62.3K Buy
593
+241
+68% +$27.3K ﹤0.01% 1635
2024
Q4 		$37.7K Buy
352
+56
+19% +$6.33K ﹤0.01% 1876
2024
Q3 		$29.6K Buy
296
+91
+44% +$9.16K ﹤0.01% 1855
2024
Q2 		$17.3K Buy
205
+44
+27% +$3.5K ﹤0.01% 1944
2024
Q1 		$11.8K Sell
161
-68
-30% -$5.01K ﹤0.01% 1971
2023
Q4 		$16.7K Buy
+229
New +$13.5K ﹤0.01% 1614

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

GAMMA Investing's LGND Position: Q3 2026 in Review

GAMMA Investing increased its Ligand Pharmaceuticals (LGND) stake by 19% in Q3 2026, buying an estimated $39K and bringing the position to 813 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #1151.

GAMMA Investing first reported a position in LGND in Q4 2023 and has held it in 12 quarters since. 14 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • GAMMA Investing held 813 shares of Ligand Pharmaceuticals worth $254K as of Q3 2026.
  • GAMMA Investing bought 132 Ligand Pharmaceuticals shares in Q3 2026, an estimated $39K.
  • Ligand Pharmaceuticals made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1151 holding.
  • GAMMA Investing first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 14 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.